Yazaki Y - Search Results

1

Overexpression of Evi-1 and dysmegakaryopoiesis in human leukemias: reply to Carapeti, Goldman and Cross, Leukemia 1996; 10: 1561.

Ogawa S, Kurokawa M, Mitani K, Yazaki Y, Hirai H. Ogawa S, et al. Among authors: yazaki y. Leukemia. 1996 Nov;10(11):1849. Leukemia. 1996. PMID: 8892696 No abstract available.

2

Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia.

Ogawa S, Kurokawa M, Tanaka T, Tanaka K, Hangaishi A, Mitani K, Kamada N, Yazaki Y, Hirai H. Ogawa S, et al. Among authors: yazaki y. Leukemia. 1996 May;10(5):788-94. Leukemia. 1996. PMID: 8656673

3

Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias.

Tanaka T, Mitani K, Kurokawa M, Ogawa S, Tanaka K, Nishida J, Yazaki Y, Shibata Y, Hirai H. Tanaka T, et al. Among authors: yazaki y. Mol Cell Biol. 1995 May;15(5):2383-92. doi: 10.1128/MCB.15.5.2383. Mol Cell Biol. 1995. PMID: 7739522 Free PMC article.

4

Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia.

Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Ohki M, Hirai H. Mitani K, et al. Among authors: yazaki y. EMBO J. 1994 Feb 1;13(3):504-10. doi: 10.1002/j.1460-2075.1994.tb06288.x. EMBO J. 1994. PMID: 8313895 Free PMC article.

5

Structurally altered Evi-1 protein generated in the 3q21q26 syndrome.

Ogawa S, Kurokawa M, Tanaka T, Mitani K, Inazawa J, Hangaishi A, Tanaka K, Matsuo Y, Minowada J, Tsubota T, Yazaki Y, Hirai H. Ogawa S, et al. Among authors: yazaki y. Oncogene. 1996 Jul 4;13(1):183-91. Oncogene. 1996. PMID: 8700545

6

No concomitant occurrence of the N-ras and p53 gene mutations in myelodysplastic syndromes.

Mitani K, Hangaishi A, Imamura N, Miyagawa K, Ogawa S, Kanda Y, Yazaki Y, Hirai H. Mitani K, et al. Among authors: yazaki y. Leukemia. 1997 Jun;11(6):863-5. doi: 10.1038/sj.leu.2400666. Leukemia. 1997. PMID: 9177441

7

Abnormal expression of Evi-1 gene in human leukemias.

Ogawa S, Mitani K, Kurokawa M, Matsuo Y, Minowada J, Inazawa J, Kamada N, Tsubota T, Yazaki Y, Hirai H. Ogawa S, et al. Among authors: yazaki y. Hum Cell. 1996 Dec;9(4):323-32. Hum Cell. 1996. PMID: 9183665

8

An acute myeloid leukemia gene, AML1, regulates transcriptional activation and hemopoietic myeloid cell differentiation antagonistically by two alternative spliced forms.

Tanaka T, Tanaka K, Ogawa S, Kurokawa M, Mitani K, Yazaki Y, Shibata Y, Hirai H. Tanaka T, et al. Among authors: yazaki y. Leukemia. 1997 Apr;11 Suppl 3:299-302. Leukemia. 1997. PMID: 9209372

9

Recent progress in molecular mechanisms of leukemogenesis: the cyclin-dependent kinase 4-inhibitor gene in human leukemias.

Hirai H, Ogawa S, Hangaishi A, Takahashi T, Kurokawa M, Mitani K, Ueda R, Yazaki Y. Hirai H, et al. Among authors: yazaki y. Leukemia. 1997 Apr;11 Suppl 3:358-60. Leukemia. 1997. PMID: 9209389

10

The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Rat1 fibroblasts with dependence on the Evi-1 sequence.

Kurokawa M, Ogawa S, Tanaka T, Mitani K, Yazaki Y, Witte ON, Hirai H. Kurokawa M, et al. Among authors: yazaki y. Oncogene. 1995 Sep 7;11(5):833-40. Oncogene. 1995. PMID: 7675444

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,089 results

Search Page

Filters